Molecular approaches in the diagnosis of sepsis in neutropenic patients with haematological malignances

Journal of Preventive Medicine and Hygiene

Volumn 53, Issue 2, 2012, Pages 104-108

  Guido, M ^a   Quattrocchi, M ^a   Zizza, A ^b   Pasanisi, G ^c   Pavone, V ^c   Lobreglio, G ^c   Gabutti, G ^d   De Donno, A ^a  

^a UNIVERSITY OF SALENTO   (Italy)

^b INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^c Cardinal G Panico Hospital   (Italy)

^d UNIVERSITY OF FERRARA   (Italy)

Author keywords

Blood culture; Epidemiology; Infection; Neutropenia; Real time PCR; Sepsis

Indexed keywords

ANTIBIOTIC AGENT;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; ASPERGILLUS FUMIGATUS; BACTERIUM DETECTION; BLOOD CULTURE; BLOOD SAMPLING; FEBRILE NEUTROPENIA; FEMALE; FUNGUS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HEMATOLOGIC MALIGNANCY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLEX POLYMERASE CHAIN REACTION; NEUTROPHIL COUNT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SEPSIS;

ADULT; AGED; AGED, 80 AND OVER; BLOOD SPECIMEN COLLECTION; FEMALE; HEMATOLOGIC NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; NEUTROPENIA; PREDICTIVE VALUE OF TESTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SEPSIS;

EID: 84864675437     PISSN: 11212233     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Martin GS, Mannino DM, Eaton S, et al. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003;348:1546-54. (Pubitemid 36437931)
2. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992;101:1644-55.
3. Angus D, Linde-Zwirble W, Lidicker J, et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001;29:1303-10. (Pubitemid 32641789)
4. Moss M, Martin GS. A global perspective on the epidemiology of sepsis. Intensive Care Med 2004;30:527-9. (Pubitemid 38530087)
5. Parrillo JE, Parker MM, Natanson C, et al. Septic shock in humans: advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann Intern Med 1990;113:227-42. (Pubitemid 20242299)
6. National Nosocomial Infections Surveillance (NNIS) System Reporty. Data Summary from January 1992 - June 2001, issued August 2001. Am J Infect Control 2001;29:404-21.
7. Friedman G, Silva E, Vincent JL. Has the mortality of septic shock changed with time? Crit Care Med 1998;26:2078-86. (Pubitemid 29016694)
8. Bernard GR, Vincent JL, Laterre PF, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001;344:699-709. (Pubitemid 32204987)
9. Danai PA, Moss M, Mannino DM, et al. The epidemiology of sepsis in patients with malignancy. Chest 2006;129:1432-40. (Pubitemid 43894970)
10. Lo N, Cullen M. Antibiotic prophylaxis in chemotherapyinduced neutropenia: time to reconsider. Hematol Oncol 2006;24,120-5. (Pubitemid 44483904)
11. Peters RP, van Agtmael MA, Danner SA, et al. New developments in the diagnosis of bloodstream infections. Lancet Infect Dis 2004;4,751-60. (Pubitemid 39574347)
12. Mancini N, Clerici D, Diotti R, et al. Molecular diagnosis of sepsis in neutropenic patients with haematological malignancies. J Med Microbiol 2008;57:601-4. (Pubitemid 351632907)
13. Lehmann LE, Hunfeld KP, Emrich T, et al. A multiplex realtime PCR assay for rapid detection and differentiation of 25 bacterial and fungal pathogens from whole blood samples. Med Microbiol Immunol 2008;197:313-24.
14. Maschmeyer G, Beinert T, Buchheidt D, et al. Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients: guidelines of the infectious diseases working party of the German Society of Haematology and Oncology. Eur J Cancer 2009;45:2462-72.
15. Lodise TP, McKinnon PS, Swiderski L, et al. Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia. Clin Infect Dis 2003;36:1418-23. (Pubitemid 36702876)
16. Carrigan SD, Scott G, Tabrizian M. Toward resolving the challenges of sepsis diagnosis. Clin Chem 2004;50:1301-14. (Pubitemid 38970636)
17. Mylotte JM, Tayara A. Blood cultures: clinical aspects and controversies. Eur J Clin Microbiol Infect Dis 2000;19:157-63. (Pubitemid 30201290)
18. Raghavan M, Marik PE. Management of sepsis during the early "golden hours". J Emerg Med 2006;31:185-99. (Pubitemid 44302056)
19. Dombrovskiy VY, Martin AA, Sunderram, J, et al. Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993-2003. Crit Care Med 2007;35:1244-50. (Pubitemid 46642649)
20. Struelens MJ, de Mendonca R. The emerging power of molecular diagnostics: towards improved management of life-threatening infection. Intensive Care Med 2001;27:1696-8. (Pubitemid 33139830)
21. Harbarth S, Garbino J, Pugin J, et al. Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. Am J Med 2003;115:529-35. (Pubitemid 37352798)
22. Kumar A, Roberts D, Wood KE, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006;34:1589-96. (Pubitemid 43810035)
23. Vince A, Lepej SZ, Barsić B, et al. LightCycler SeptiFast assay as a tool for the rapid diagnosis of sepsis in patients during antimicrobial therapy. J Med Microbiol 2008;57:1306-7.
24. Varani S, Stanzani M, Paolucci M, et al. Diagnosis of bloodstream infections in immunocompromised patients by real-time PCR. J Infect 2009;58:346-51.
25. Feld R. Bloodstream infections in cancer patients with febrile neutropenia. Int J Antimicrob Agents 2008;32(Suppl 1):S30-3.
26. Penack O, Rempf P, Eisenblätter M, et al. Bloodstream infections in neutropenic patients: early detection of pathogens and directed antimicrobial therapy due to surveillance blood cultures. Ann Oncol 2007;18:1870-4.
27. Ammann RA, Zucol F, Aebi C, et al. Real-time broad-range PCR versus blood culture. A prospective pilot study in pediatric cancer patients with fever and neutropenia. Support Care Cancer 2007;15:637-41. (Pubitemid 47034995)